Jenny Harrington, an expert in investment strategies, shares insights on buying medical technology stocks. The episode covers market anticipation of the inflation report, Josh Brown doubling up on Amazon, Micron's earnings dip, and trade updates from Bill Baruch. The investment committee also discusses stock breakouts, market analysis, economic anticipation, stock downgrades, and performance reviews of various stocks.
Josh Brown's bullish sentiment on Amazon reflects positive trading moves and signals a potential breakout.
Intel's stock decline is expected to recover with improved execution, projected earnings increase, and market challenges addressed.
Deep dives
Amazon's Stock Performance and Bullish Outlook
Amazon's stock performance has been remarkable as it approaches a $2 trillion market cap, with significant support and positive trading moves. Josh Brown's decision to double his position in Amazon reflects a strong bullish sentiment, driven by key triggers like Amazon's breakout and positive fundamental indicators.
Intel's Turnaround Prospects and Stock Performance
Intel's stock displays a significant decline of 31%, reflecting market challenges. However, with a projected earnings increase to $2 per share, Intel's future potential looks promising. Patiently waiting for Intel's execution to improve its financial performance is anticipated to lead to significant stock value recovery.
Cleveland Cliffs: Balancing Cash Management and Market Challenges
Cleveland Cliffs faces a 35% stock decline due to decreased hot rolled coil pricing. The company's strategic focus on managing cash reserves and resolving uncertainties around potential acquisitions like US Steel impacts its stock performance. The next quarterly report is crucial for revealing Cleveland Cliffs' future directions.
Zimmer Holdings: Growth Strategy and Recovery Potential
Zimmer Holdings' market share in hip and knee sectors positions it well for recovery despite an 11% stock decline. Investments in R&D, cost-cutting measures, debt reduction, and potential acquisitions foretell 8-10% earnings growth. Zimmer Holdings' steady growth trajectory highlights undervalued potential for substantial stock value appreciation.
Scott Wapner and the Investment Committee debate how much is hinging on tomorrow’s inflation report, as the first half of the year comes to a close. Josh Brown doubles his position in Amazon. Micron dips after earnings; Bill Baruch is back with a trade update. The calls of the day include Rio Tinto, Coca-Cola, Disney and AT&T. Jenny Harrington explains why she’s buying more of one medical technology stock.